Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase EARLY_PHASE1 1

Status

Completed 24Unknown 5Terminated 5Recruiting 3Active not recruiting 3Withdrawn 2Not yet recruiting 2Suspended 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

CNS 3Sarcoma 1

Conditions

Carcinoma, Non-Small-Cell Lung 10Rectal Neoplasms 9Squamous Cell Carcinoma of Head and Neck 8Sarcoma 8Stomach Neoplasms 7Esophageal Neoplasms 7Breast Neoplasms 7Neoplasms 5Lung Neoplasms 5Hypopharyngeal Neoplasms 5Carcinoma, Hepatocellular 5Recurrence 4Prostatic Neoplasms 4Pancreatic Neoplasms 4Oropharyngeal Neoplasms 4Neoplasm Metastasis 4Thyroid Neoplasms 3Nasopharyngeal Carcinoma 3Melanoma 3Laryngeal Neoplasms 3Head and Neck Neoplasms 3Glioma 3Glioblastoma 3Colorectal Neoplasms 3Urinary Bladder Neoplasms 2Osteosarcoma 2Mouth Neoplasms 2Hyperthermia 2Fallopian Tube Neoplasms 2Endometrial Neoplasms 2

Interventions

Temozolomide 45Radiotherapy 17Magnetic Resonance Spectroscopy 17Specimen Handling 14pembrolizumab 12Bevacizumab 12Lomustine 9Radiation 8fludarabine 7Cyclophosphamide 7atezolizumab 4Biopsy 4olaparib 3Transurethral Resection of Bladder 3Surgical Procedures, Operative 3Nivolumab 3Leukapheresis 3D2C7-(scdsFv)-PE38KDEL 3Blood Specimen Collection 3Aminolevulinic Acid 3regorafenib 2fluciclovine F-18 2contrast agent BR1 2antisecretory factor 2abemaciclib 2Restraint, Physical 2Re-Irradiation 2Radiation Dose Hypofractionation 2Palliative Care 2Oncolytic Virotherapy 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Recruiting × Glioblastoma × Surgical Procedures, Operative × Clear all
NCT07301268 2026-04-08

GI-102 Alone or With Pembrolizumab Before Surgery for Treatment of Recurrent or Progressive IDH Wildtype Glioblastoma and IDH Mutated Grade 4 Astrocytoma

Mayo Clinic

Phase 2 Recruiting
36 enrolled
CNSSarcoma

Astrocytoma, Glioblastoma, Gliosarcoma

NCT05879250 2025-12-30

WP1066 and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma

Northwestern University

Phase 2 Recruiting
39 enrolled
CNS

Glioblastoma

NCT06831526 2025-11-12

Neoadjuvant Chemoradiotherapy With or Without Concurrent Azeliragon in Patients With Newly Diagnosed Glioblastoma

Washington University School of Medicine

Phase EARLY_PHASE1 Recruiting
12 enrolled
CNS

Glioblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡